Cargando…
Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance
Alzheimer’s disease (AD) is the main type of dementia and is a disease with a profound socioeconomic burden due to the lack of effective treatment. In addition to genetics and environmental factors, AD is highly associated with metabolic syndrome, defined as the combination of hypertension, hyperlip...
Autores principales: | Ezkurdia, Amaia, Ramírez, María J., Solas, Maite |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001958/ https://www.ncbi.nlm.nih.gov/pubmed/36901787 http://dx.doi.org/10.3390/ijms24054354 |
Ejemplares similares
-
Brain Metabolic Alterations in Alzheimer’s Disease
por: Ardanaz, Carlos G., et al.
Publicado: (2022) -
JNK3 Overexpression
in the Entorhinal Cortex Impacts
on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding
por: Ardanaz, Carlos G., et al.
Publicado: (2023) -
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016) -
Iron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
por: Chung, Ji Yeon, et al.
Publicado: (2018) -
Biomarkers in Alzheimer’s disease
por: Janeiro, Manuel H., et al.
Publicado: (2020)